CooperVision has received the US Food and Drug Administration's (FDA) 510(k) approval for its Avaira Toric two-week silicone hydrogel contact lenses to treat astigmatism.
Avaira Toric contact lenses have a ballast design for lens stability and provide patients with a comfortable lens wearing experience.
Avaira contact lenses are designed with an ability to attract and retain moisture within the lens material without the need for surface treatment or wetting agents.
CooperVision said the consistent fit of Avaira Toric lenses provides eye care practitioners an option for a wide range of astigmatic patients.